Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Dynein light chain Tctex-type 3 pseudogene 1 (DYNLT3P1)** is a non-coding pseudogene related to the dynein light chain Tctex-type 3 (DYNLT3) gene. Unlike the protein-coding DYNLT3 gene involved in cytoplasmic dynein motor function and spindle checkpoint regulation[1][3], DYNLT3P1 does not encode a functional protein and currently has no documented role as a therapeutic target, biological function, or disease association. Its classification as a pseudogene means it may be a non-functional segment arising from duplication or retrotransposition of the DYNLT3 gene[6]. There is no evidence suggesting DYNLT3P1 is involved in gene regulation or disease, nor interacting drugs, and it should not be considered a therapeutic target. **Key clarification:** DYNLT3P1 is not a receptor, enzyme, transporter, or any recognized molecular therapeutic target; instead, it is a pseudogene. Referenced data indicate its entry as a pseudogene and lack of protein-coding potential or direct biological function[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein light chain Tctex-type 3 pseudogene 1 (DYNLT3P1).